Patent · US Active

Cyclic diaminopyrimidine derivatives

US9073944B2 · kind B2 · utility

1Cited by

0References

6Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Henry Yu · Wellesley, US
Lizbeth Celeste Deselm · Melrose, US

Key dates

Filing date	Dec 18, 2012
Grant date	Jul 7, 2015
Priority date	—
Expiry date	Dec 18, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula Iin which A, L1, L2, X and Y have the meanings indicated in Claim 1, are inhibitors of Syk, and can be employed, inter alia, for the treatment of rheumatoid arthritis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.